These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis. Tang A; Hallouch O; Chernyak V; Kamaya A; Sirlin CB Abdom Radiol (NY); 2018 Jan; 43(1):13-25. PubMed ID: 28647765 [TBL] [Abstract][Full Text] [Related]
5. Epidemiology and natural history of hepatocellular carcinoma. McGlynn KA; London WT Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):3-23. PubMed ID: 15757802 [TBL] [Abstract][Full Text] [Related]
6. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Kew MC Pathol Biol (Paris); 2010 Aug; 58(4):273-7. PubMed ID: 20378277 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology and clinical presentation of hepatocellular carcinoma. Di Bisceglie AM J Vasc Interv Radiol; 2002 Sep; 13(9 Pt 2):S169-71. PubMed ID: 12354833 [TBL] [Abstract][Full Text] [Related]
8. Epidemiological projections of viral-induced hepatocellular carcinoma in the perspective of WHO global hepatitis elimination. Vo Quang E; Shimakawa Y; Nahon P Liver Int; 2021 May; 41(5):915-927. PubMed ID: 33641230 [TBL] [Abstract][Full Text] [Related]
9. Risk stratification in chronic hepatitis B patients for hepatocellular carcinoma surveillance: management in migrant sub-Saharan African populations. Cargill Z; Brown SE; Dusheiko G; Agarwal K Gut; 2021 Mar; 70(3):629-630. PubMed ID: 32606207 [No Abstract] [Full Text] [Related]
10. [Epidemiology, natural history, and risk factors of hepatocellular carcinoma]. Fares N; Péron JM Rev Prat; 2013 Feb; 63(2):216-7, 220-2. PubMed ID: 23513788 [TBL] [Abstract][Full Text] [Related]
11. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Venook AP; Papandreou C; Furuse J; de Guevara LL Oncologist; 2010; 15 Suppl 4():5-13. PubMed ID: 21115576 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus infection and hepatocellular carcinoma in sub-Saharan Africa: Implications for elimination of viral hepatitis by 2030? Amponsah-Dacosta E World J Gastroenterol; 2021 Sep; 27(36):6025-6038. PubMed ID: 34629817 [TBL] [Abstract][Full Text] [Related]
17. Disease Burden of Hepatocellular Carcinoma: A Global Perspective. Sayiner M; Golabi P; Younossi ZM Dig Dis Sci; 2019 Apr; 64(4):910-917. PubMed ID: 30835028 [TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma in sub-Saharan Africa - the way forward. Jonas E S Afr Med J; 2018 Aug; 108(8b):12391. PubMed ID: 30182914 [TBL] [Abstract][Full Text] [Related]
19. Current epidemiology in hepatocellular carcinoma. Konyn P; Ahmed A; Kim D Expert Rev Gastroenterol Hepatol; 2021 Nov; 15(11):1295-1307. PubMed ID: 34624198 [TBL] [Abstract][Full Text] [Related]
20. [Antiviral therapy and risk for hepatocellular carcinoma in chronic viral hepatitis]. Abdurakhmanov DT Ter Arkh; 2013; 85(10):94-7. PubMed ID: 24437226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]